A PGE2-derivative for quantitative gas chromatographic mass spectrometric measurement in the selected ion monitoring mode.
The quantification of prostaglandin PGE2 by gas chromatography mass spectrometry in the form of an easily prepared derivative is described. After extraction and purification of biological samples the compound was derivatized in two steps to 9-enol-PGE2- methylester - trimethylsilylether , 9-enol-PGE2-Me- TMS3 . The molecular ion at m/z 582 with 40% relative abundance and the fragment ion at m/z 492 with 100% relative abundance permit a specific and sensitive evaluation in the selected ion monitoring mode. The high masses selected lie above the biological background. The calibration curve produced by adding known amounts (10-200 ng) of PGE2 to blank human urine and with (2H4)-deuterated PGE2 as internal standard gave a linear correlation. The separation from biological impurities was obtained on a 50 m glass capillary column and resulted in sharp and symmetrical peaks.
D000328:Adult; D015232:Dinoprostone / Q000031:analogs & derivatives; D005260:Female; D008401:Gas Chromatography-Mass Spectrometry; D006801:Humans; D011458:Prostaglandins E / Q000032:analysis* / Q000652:urine; D011459:Prostaglandins E, Synthetic / Q000032:analysis*
D011458:Prostaglandins E; D011459:Prostaglandins E, Synthetic; C041624:9-enol-prostaglandin E2 methyl ester trimethylsilyl ether; D015232:Dinoprostone